Blog

54 Articles

Dr. Alison Klein, pancreatic cancer researcher
Research
November 7, 2022 • 6 Min

Putting Familial Risk In Perspective

Dr. Alison Klein works to understand the relationship between familial risk and the chances of developing pancreatic cancer.

Webinar, Symptoms and Risks
Webinars
October 28, 2022 • 1 Min

Symptoms and Risk Factors

Moderator Daniel G Garza leads Dr. Rachna Shroff and Dr. Fiyinfolu Balogun in a discussion of risk factors and symptoms of pancreatic cancer.

circular flashes of red yellow and green light against a black background
Research
May 26, 2022 • 3 Min

Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver

Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?

Dr. Neeha Zaidi
Research
April 18, 2022 • 6 Min

New Immunotherapy Strategy Aimed at High-Risk Population

Dr. Neeha Zaidi is the lead investigator of an immunotherapy trial using a vaccine for people at high risk for pancreatic cancer.

Dr. Nicolette Rodriguez
Research
March 21, 2022 • 5 Min

New Study to Get More Minorities Involved in Genetic Testing

Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.

orange and purple topped blood vials in a yellow tray
Symptoms
February 9, 2022 • 5 Min

Understanding Who Is at High Risk for Pancreatic Cancer

Dr. Matthew Yurgelun explains what high risk means for pancreatic cancer, and outlines what you can do if you meet these criteria.

microscope on a blue background
Research
December 29, 2021 • 8 Min

Pancreatic Cancer Science—2021 in Review

As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.

Gastroenterologist Dr. Venkata Akshintala
Symptoms
September 20, 2021 • 4 Min

Precursors to Pancreatic Cancer: Are There Any Signs to Watch Out For?

Dr. Venkata Akshintala outlines some of the precursors to pancreatic cancer that people should look out for.

orange and blue kaleidoscopic pattern
Research
August 11, 2021 • 2 Min

Testing a PARP Inhibitor for Metastatic Pancreatic Cancer Patients with DNA Repair Mutations

Researchers are testing a PARP inhibitor that is effective for cancers in pancreatic cancer patients with DNA repair mutations.

Gehan Botrus
Research
July 26, 2021 • 5 Min

Finding More Clues about Circulating Tumor DNA

Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.

Lab worker holding pipette
Research
July 16, 2021 • 2 Min

Identifying Biomarkers for Early Detection of Pancreatic Cancer

A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.

abstract DNA image in bright greens and reds
Research
May 25, 2021 • 2 Min

PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations

A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.

multicolored abstract DNA against a black background
Research
April 29, 2021 • 3 Min

Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer

A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.

Learn the Risk Factors webinar announcement
Webinars
February 26, 2021 • 1 Min

Learn the Risk Factors

In the first Let’s Learn webinar, Learn the Risk Factors, experts explain how diabetes, genetic mutations, and pancreatitis impact pancreatic cancer.

Green and red microscope
Research
December 30, 2020 • 6 Min

A Year in Review: 2020

In March 2020, life as we knew it changed. The way we work, the way we gather, the way we each live our daily lives all felt upended, seemingly overnight. The global pandemic of COVID-19 affected everything, including cancer care and research. COVID-19 brought new risks to cancer patients, whose immune systems are compromised from […]